GM-CSF from the vector activates GM-CSF receptor–expressing myeloid cells; they are not killed. Killing occurs in HSV-tk–transduced tumor cells after valganciclovir is converted to ganciclovir triphosphate (DNA synthesis inhibition) and via subsequent T/NK-cell–mediated tumor killing.